Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePOLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB OR OBINUTUZUMAB IN RELAPSED/REFRACTORY FL OR DLBCL: UPDATED RESULTS OF A PHASE 1B/2 STUDY.AuthorsMatasar, M.; Herrera, A.F.; Kamdar, M.; Mehta, A.; Assouline, S.; Fleury, I.; Kim, T.M.; Kim, W.S.; Bosch, F.; Radford, J.; Flowers, C.R.; Bu, L.; Hong, W.; Sehn, L.H.PublicationHematological Oncology, 2017, Vol 35, p271ISSN0278-0232Publication typeArticleDOI10.1002/hon.2438_144